Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lowe

Showing results (381-390 of 561) with videos related to

Pageof 57
Sort By:
Cell|November 2, 1990
ELAM-1--dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNAJ B Lowe, L M Stoolman, R P Nair, et al.
The New Zealand Medical Journal|December 8, 1982
Infective endocarditis: prudent treatment for a lethal diseaseJ D Rutherford, T M Agnew, J M Neutze, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2004
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunityRonald C Kennedy, Michael H Shearer, Devin B Lowe, et al.
The Journal of Cell Biology|May 1, 1996
The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cellsR N Knibbs, R A Craig, S Natsuka, et al.
Internal Medicine Journal|September 17, 2016
Eosinophilic myocarditis: characteristics, diagnostics and outcomes of a rare conditionT K M Wang, T Watson, J Pemberton, et al.
American Journal of Health Promotion : AJHP|September 13, 2008
Paths to leisure physical activity among adults with intellectual disabilities: self-efficacy and social supportJana J Peterson, John B Lowe, N Andrew Peterson, et al.
Drug and Alcohol Review|February 18, 2004
Smoking behaviour among Indigenous secondary school students in North QueenslandJohn B Lowe, Lynette Saeck, Mark Brough, et al.
Nature|July 8, 1993
Protective effects of oligosaccharides in P-selectin-dependent lung injuryM S Mulligan, J C Paulson, S De Frees, et al.
Journal of Medical Screening|April 12, 2002
A randomised trial of population screening for melanomaJ F Aitken, J M Elwood, J B Lowe, et al.
Oncoimmunology|April 16, 2014
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanomaDevin B Lowe, Anamika Bose, Jennifer L Taylor, et al.
Pageof 57

Showing results (381-390 of 561) with videos related to

Sort By:
Pageof 57
Cell|November 2, 1990
ELAM-1--dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNAJ B Lowe, L M Stoolman, R P Nair, et al.
The New Zealand Medical Journal|December 8, 1982
Infective endocarditis: prudent treatment for a lethal diseaseJ D Rutherford, T M Agnew, J M Neutze, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2004
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunityRonald C Kennedy, Michael H Shearer, Devin B Lowe, et al.
The Journal of Cell Biology|May 1, 1996
The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cellsR N Knibbs, R A Craig, S Natsuka, et al.
Internal Medicine Journal|September 17, 2016
Eosinophilic myocarditis: characteristics, diagnostics and outcomes of a rare conditionT K M Wang, T Watson, J Pemberton, et al.
American Journal of Health Promotion : AJHP|September 13, 2008
Paths to leisure physical activity among adults with intellectual disabilities: self-efficacy and social supportJana J Peterson, John B Lowe, N Andrew Peterson, et al.
Drug and Alcohol Review|February 18, 2004
Smoking behaviour among Indigenous secondary school students in North QueenslandJohn B Lowe, Lynette Saeck, Mark Brough, et al.
Nature|July 8, 1993
Protective effects of oligosaccharides in P-selectin-dependent lung injuryM S Mulligan, J C Paulson, S De Frees, et al.
Journal of Medical Screening|April 12, 2002
A randomised trial of population screening for melanomaJ F Aitken, J M Elwood, J B Lowe, et al.
Oncoimmunology|April 16, 2014
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanomaDevin B Lowe, Anamika Bose, Jennifer L Taylor, et al.
Pageof 57